Quarterly report pursuant to Section 13 or 15(d)

Net Income (Loss) Per Share (Tables)

v3.20.4
Net Income (Loss) Per Share (Tables)
3 Months Ended
Dec. 31, 2020
Net Income (Loss) Per Share [Abstract]  
Schedule Of Earnings Per Share, Basic And Diluted



 

 

 

 

 



Three Months Ended



December 31,



2020

 

2019



 

 

 

 

 

Net income (loss)

$

17,227,701 

 

$

(3,305,101)



 

 

 

 

 

Basic weighted average common shares outstanding

 

70,313,589 

 

 

65,038,511 

Net effect of dilutive instruments:

 

 

 

 

 

Stock options

 

4,421,341 

 

 

 —

Stock appreciation rights

 

38,527 

 

 

 —

Common stock purchase warrants

 

1,025,580 

 

 

 —

Total net effect of dilutive instruments

 

5,485,448 

 

 

 —

Diluted weighted average common shares outstanding

 

75,799,037 

 

 

65,038,511 

Net income (loss) per basic common share outstanding

$

0.25 

 

$

(0.05)

Net income (loss) per diluted common share outstanding

$

0.23 

 

$

(0.05)